Alkem Laboratories is currently trading at Rs. 1776.45, up by 26.40 points or 1.51% from its previous closing of Rs. 1750.05 on the BSE.
The scrip opened at Rs. 1757.50 and has touched a high and low of Rs. 1780.00 and Rs. 1757.50 respectively.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2265.00 on 10-Sep-2018 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.
Last one week high and low of the scrip stood at Rs. 1795.00 and Rs. 1715.00 respectively. The current market cap of the company is Rs. 21240.12 crore.
The promoters holding in the company stood at 66.03%, while Institutions and Non-Institutions held 8.69% and 25.28% respectively.
SBI Mutual Fund (SBI MF) and Aditya Birla Sun Life Mutual Fund have bought shares of Alkem Laboratories worth around Rs 538 crore through open market transactions.
SBI MF has bought 24 lakh shares and Aditya Birla Sun Life MF has purchased 7.5 lakh shares of the company for Rs 1,708.45 per share, while SBI MF has bought the shares for Rs 410.02 crore, Aditya Birla has acquired scrips for Rs 128.13 crore.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.